June 23, 2023
January 25, 2025
This week’s newsletter included:
- Owlet Announces FDA Clearance of the First Prescription Pulse Oximetry Sock for Infants
- CMS Issues Transitional Coverage for Emerging Technologies Pathway
- Hexamer Therapeutics, Innovative Vaccine Technologies Receive Federal Funding for Breakthrough Vaccine Technology
- Elizabeth R. Cantwell Named 17th USU President
- BioUtah Hosts Monthly Legislative Policy Call – Join Us
Featured New Member: Biostone Biologics
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize
